Powl Brian T. 4
4 · Kura Oncology, Inc. · Filed Jan 28, 2025
Insider Transaction Report
Form 4
Powl Brian T.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2025-01-28$7.87/sh−1,583$12,461→ 59,667 total
Footnotes (1)
- [F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24.